SYS-CON MEDIA Authors: Greg Schulz, Gilad Parann-Nissany, Kevin Benedict, RealWire News Distribution, Unitiv Blog

News Feed Item

Zacks Investment Ideas feature highlights: Medbox

CHICAGO, Jan. 10, 2014 /PRNewswire/ -- Today, Zacks Investment Ideas feature highlights Features: Medbox (OTC:MDBX-Free Report).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Getting High on Pot Stocks

Are you stressed out and need a release? Boss got you singing the blues? Well if you are in Colorado, you roll a fat one and as the kids say "chillax."

I am not sure what "chillax" means, but it appears to be a combination of chill out and relax. Seems to me they want to do the same thing twice as hard, which just gives me faith in our collective futures.

With all the stories of legalized weed, I decided to take a look at this topic a little more closely. I first took a look at http://www.marijuana.com/ to learn about this green plant and what it can do. Then I saw some tweets about something call "kush" selling for $400 an ounce and I nearly fell back into the couch and dreamed of easy money.

I mean, $400 an ounce, 16 ounces in a pound, it sounds like I don't need to dream of being Walter White anymore... more like Fritz Haber.

The Green Rush

The gold rush sent tons of people west with the promise of riches hoping that they would "pan out." Today, a similar rush, just of the green variety has people moving west looking to "pot out."

But there are some road blocks in place that are preventing us regular people from just setting up shop in CO or WA. Maybe it would just be easier to buy stock in a company that is already doing that! DUDE!

Recently I have been watching Growlife and how it has gotten so high lately. Then I saw that it's a penny stock, and doesn't have a Zacks Rank, so I cannot pass this joint to the left hand side.

Medbox (OTC:MDBX-Free Report) is another player in this green space. They have a little different take on the business as they have a machine that dispenses medication to individuals based on biometric identification (fingerprints).

Dude! What a great idea! I mean I don't even have to converse with another human when I am going to get my fix! But seriously, the firm is just selling the machines and not the green, so this is an example of buying the bullet makers and not the army in time of war.

MDBX does not have a Zacks Rank either. I am seeing a trend here.

I Could Ramble On and On and On

I kept looking for a stock that fits this new green space. But the more I looked, the more I found penny stocks that have ripped higher. None of which had a Zacks Rank.

What does that mean for me? Well that means I cannot recommend a good pot stock. I can only sit back and watch as these stocks fire up as the green rush gets underway. What will change my mind and get on bong... I mean on board, is if some analysts pick up coverage of the sector. Then, with earnings estimates, the stock would become eligible for a Zacks Rank.

Conclusion

Pot stocks are hot, but investors may get burned if they are not careful. The Zacks Rank will help you find the stocks that are seeing earnings estimate revisions, and that insight can help you stick with a higher flyer and prevent you from coming down from a big high too. As much as I want to recommend one or more of these stocks, I cannot, but if there are any analysts willing to do a deep dive into the jungle of pot stocks, I am sure you will have an instant following!

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.

Get the full Report on MDBX – FREE

Follow us on Twitter:  http://twitter.com/ZacksResearch

Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

SOURCE Zacks Investment Research, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.